TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 47 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $3,000 | -57.1% | 821 | -19.6% | 0.00% | – |
Q1 2022 | $7,000 | -41.7% | 1,021 | 0.0% | 0.00% | – |
Q4 2021 | $12,000 | -36.8% | 1,021 | 0.0% | 0.00% | – |
Q3 2021 | $19,000 | -13.6% | 1,021 | 0.0% | 0.00% | – |
Q2 2021 | $22,000 | +10.0% | 1,021 | +6.2% | 0.00% | – |
Q1 2021 | $20,000 | +5.3% | 961 | +33.5% | 0.00% | – |
Q4 2020 | $19,000 | +137.5% | 720 | +94.6% | 0.00% | – |
Q3 2020 | $8,000 | – | 370 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Capital Investment Advisors, LLC | 10,000 | $17,700 | 0.00% |